Based on the search results, I can see you’re asking about PHAT (Phathom Pharmaceuticals) stock information and news. Here’s what I found:
PHAT (Phathom Pharmaceuticals) is currently trading at $6.26 per share with a minimal change of 0.06%[1].
According to the information from moomoo.com, PHAT stock rose 22% last week, although insiders who sold shares worth $832,000 over the past year might be in a more advantageous position[2].
The stock information is available on various financial platforms including Sina Finance, East Money, and Futunn, which provide real-time quotes, news, financial reports, and analysis related to PHAT stock[1][3].
For options trading, there appears to be a PHAT call option expiring on June 20, 2025, with a strike price of $2.50. This option has an implied volatility of 416.20% and a premium of 1.28%[4].
Unfortunately, there doesn’t appear to be any specific breaking news about PHAT in the search results beyond the general stock performance information. The most notable recent development mentioned is the 22% rise in stock price from last week[2].